We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FNA icon
251
DELISTED
Paragon 28, Inc.
FNA
$1.65M 0.03%
131,285
+45,000
+52% +$679K
2023 Q1
2 quarters
AGEN icon
252
Agenus
AGEN
$314M
$1.63M 0.03%
72,204
+1,500
+2% +$42.5K
2022 Q1
6 quarters
CCL icon
253
PUT
Carnival Corporation Ltd
CCL
$35.9B
$1.62M 0.03%
915,000
+665,000
+266% +$11M
2021 Q3
8 quarters
ALGN icon
254
Align Technology
ALGN
$10.2B
$1.62M 0.03%
5,300
+409
+8% +$141K
2022 Q4
3 quarters
VTYX icon
255
DELISTED
Ventyx Biosciences
VTYX
$1.58M 0.03%
45,463
-13,000
-22% -$449K
2022 Q3
4 quarters
ALCYU icon
256
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
$1.57M 0.03%
150,000
– –
2023 Q2
1 quarter
BCYC icon
257
Bicycle Therapeutics
BCYC
$254M
$1.57M 0.03%
77,902
– –
2022 Q1
6 quarters
LADR icon
258
Ladder Capital
LADR
$1.11B
$1.56M 0.03%
+152,300
New +$1.65M
2023 Q3
0 quarters
RAPT icon
259
DELISTED
RAPT Therapeutics
RAPT
$1.56M 0.03%
11,727
-375
-3% -$61.2K
2022 Q2
5 quarters
ASAN icon
260
Asana
ASAN
$2.26B
$1.56M 0.03%
85,000
+63,490
+295% +$1.33M
2023 Q1
2 quarters
GKOS icon
261
Glaukos
GKOS
$9.76B
$1.54M 0.03%
20,471
-20,000
-49% -$1.49M
2022 Q1
6 quarters
HLVX icon
262
DELISTED
HilleVax
HLVX
$1.54M 0.03%
114,478
+34,000
+42% +$479K
2022 Q2
5 quarters
ETNB icon
263
DELISTED
89bio
ETNB
$1.53M 0.03%
98,838
+15,000
+18% +$252K
2022 Q3
4 quarters
HYAC icon
264
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.53M 0.03%
+150,000
New +$1.53M
2023 Q3
0 quarters
ETSY icon
265
Etsy
ETSY
$7.28B
$1.52M 0.03%
+23,500
New +$1.85M
2023 Q3
0 quarters
BBIO icon
266
BridgeBio Pharma
BBIO
$12.4B
$1.51M 0.03%
+57,300
New +$1.63M
2023 Q3
0 quarters
SRRK icon
267
Scholar Rock
SRRK
$4.93B
$1.51M 0.03%
212,581
+10,000
+5% +$67.2K
2022 Q2
5 quarters
INSM icon
268
Insmed
INSM
$21.1B
$1.5M 0.03%
59,292
-53,000
-47% -$1.21M
2022 Q1
6 quarters
LRMR icon
269
Larimar Therapeutics
LRMR
$224M
$1.5M 0.03%
378,505
+15,000
+4% +$56.7K
2022 Q4
3 quarters
TMO icon
270
Thermo Fisher Scientific
TMO
$245B
$1.49M 0.03%
2,950
-5,500
-65% -$2.93M
2023 Q2
1 quarter
LBPH icon
271
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.46M 0.03%
262,265
– –
2023 Q1
2 quarters
SVRA icon
272
Savara
SVRA
$982M
$1.44M 0.03%
380,352
-20,000
-5% -$71.3K
2022 Q2
5 quarters
VRNA
273
DELISTED
Verona Pharma
VRNA
$1.43M 0.03%
87,628
– –
2022 Q3
4 quarters
OPRA icon
274
Opera Ltd
OPRA
$1.61B
$1.41M 0.03%
+125,000
New +$2.09M
2023 Q3
0 quarters
INCY icon
275
Incyte
INCY
$22B
$1.41M 0.03%
24,349
-32,000
-57% -$2.02M
2023 Q1
2 quarters
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.